813 research outputs found
La colección de preparados palinológicos de la Cátedra de Palinología de la Facultad de Ciencias Naturales y Museo (FCNyM), Universidad Nacional de La Plata (UNLP), Buenos Aires, Argentina
Fil: Yañez, Agustina. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Museo Argentino de Ciencias Naturales "Bernardino Rivadavia"; ArgentinaFil: Macluf, Carmen Cecilia. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; ArgentinaFil: Mallo, Andrea Cecilia. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; ArgentinaFil: Giudice, Gabriela Elena. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; ArgentinaFil: Pasarelli, Lilian. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; ArgentinaFil: Marquez, Gonzalo Javier. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Ramos Giacosa, Juan Pablo. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Morbelli, Marta Alicia. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Piñeiro, Maria Raquel. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Copello, Manuel. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; ArgentinaFil: Nitiu, Daniela Silvana. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Kelly, Santiago Julián. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Instituto de Fisiología Vegetal. Universidad Nacional de la Plata. Facultad de Cs.naturales y Museo. Instituto de Fisiología Vegetal; ArgentinaFil: Quetglas, Marcela Alejandra. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: San Martin, Cintia Marta. Universidad Nacional de la Plata. Facultad de Ciencias Naturales y Museo. Cátedra de Palinología; Argentin
Knowledge, attitudes and preventive practices of primary health care professionals towards alcohol use: A national, cross-sectional study.
Introduction
Primary care (PC) professionals' knowledge about alcohol use has been identified as one of the barriers PC providers face in their clinic. Both PC professionals’ level of training and attitude are crucial in the clinical practice regarding alcohol use.
Objective
To evaluate the knowledge, attitude, and preventive practices of Spanish PC physicians and nurses towards alcohol use.
Design
An observational, descriptive, cross-sectional, multi-center study.
Methodology
Location: PC centers of the Spanish National Health System (NHS). Participants: PC physicians and nurses selected randomly from health care centers, and by sending an e-mail to semFYC and SEMERGEN members. Healthcare providers completed an online survey on knowledge, attitude, and follow-up recommendations for reducing alcohol intake. A descriptive, bivariate, and multivariate statistical analysis was conducted (p<0.05).
Results
Participants: 1,760 healthcare providers completed the survey (75.6% [95% CI 73.5–77.6] family physicians; 11.4% [95% CI 9.9–12.9] medical residents; and 12.5% [95% CI 10.9–14.1] nurses), with a mean age of 44.7 (SD 11.24, range: 26–64, 95% CI: 47.2–48.2). Knowledge was higher in family physicians (p<0.001), older professionals (Spearman's r = 0.11, p<0.001), and resident trainers (p<0.001). The PC professional most likely to provide advice for reducing alcohol use was: a nurse (p <0.001), female (p = 0.010), between 46 and 55 years old (p <0.001).
Conclusions
PC providers’ knowledge and preventive practices regarding alcohol use are scarce, hence specific training strategies to increase their knowledge and improve their attitude and skills with regard to this health problem should be considered a healthcare policy priority.post-print507 K
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept
Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers
that could enable personalized treatments. The genetic biomarkers associated with the
response to TNF inhibitors (TNFi) are among the most studied. They include 12 SNPs
exhibiting promising results in the three largest genome-wide association studies (GWAS).
However, they still require further validation. With this aim, we assessed their association
with response to TNFi in a replication study, and a meta-analysis summarizing all nonredundant
data. The replication involved 755 patients with RA that were treated for the first
time with a biologic drug, which was either infliximab (n = 397), etanercept (n = 155) or adalimumab
(n = 203). Their DNA samples were successfully genotyped with a single-base
extension multiplex method. Lamentably, none of the 12 SNPs was associated with
response to the TNFi in the replication study (p > 0.05). However, a drug-stratified exploratory
analysis revealed a significant association of the NUBPL rs2378945 SNP with a poor response to etanercept (B = -0.50, 95% CI = -0.82, -0.17, p = 0.003). In addition, the metaanalysis
reinforced the previous association of three SNPs: rs2378945, rs12142623, and
rs4651370. In contrast, five of the remaining SNPs were less associated than before, and
the other four SNPs were no longer associated with the response to treatment. In summary,
our results highlight the complexity of the pharmacogenetics of TNFi in RA showing that it
could involve a drug-specific component and clarifying the status of the 12 GWAS-drawn
SNPsThis work was supported by the Instituto
de Salud Carlos III (ISCIII, Spain) through grants
PI14/01651, PI17/01606 and RD16/0012/0014 to
AG and PI12/01909 to JJG-R. These grants are
partially financed by the European Regional
Development Fund of the EU (FEDER
Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum:the multicentric SENCOVAC study
Citizen science and online data: Opportunities and challenges for snake ecology and action against snakebite
The secretive behavior and life history of snakes makes studying their biology, distribution, and the epidemiology of venomous snakebite challenging. One of the most useful, most versatile, and easiest to collect types of biological data are photographs, particularly those that are connected with geographic location and date-time metadata. Photos verify occurrence records, provide data on phenotypes and ecology, and are often used to illustrate new species descriptions, field guides and identification keys, as well as in training humans and computer vision algorithms to identify snakes. We scoured eleven online and two offline sources of snake photos in an attempt to collect as many photos of as many snake species as possible, and attempt to explain some of the inter-species variation in photograph quantity among global regions and taxonomic groups, and with regard to medical importance, human population density, and range size. We collected a total of 725,565 photos—between 1 and 48,696 photos of 3098 of the world's 3879 snake species (79.9%), leaving 781 “most wanted” species with no photos (20.1% of all currently-described species as of the December 2020 release of The Reptile Database). We provide a list of most wanted species sortable by family, continent, authority, and medical importance, and encourage snake photographers worldwide to submit photos and associated metadata, particularly of “missing” species, to the most permanent and useful online archives: The Reptile Database, iNaturalist, and HerpMapper.ISSN:2590-171
Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients
Background: Data on which to base definitive recommendations on the doses and duration of therapy for genotype 3 HCV/HIV-coinfected patients are scarce. We evaluated the efficacy of a lower peginterferon-α 2a dose and a shorter duration of therapy than the current standard of care in genotype 3 HCV/HIV-coinfected patients. Methods and Findings: Pilot, open-label, single arm clinical trial which involved 58 Caucasian HCV/HIV-coinfected patients who received weekly 135 μg peginterferon-α 2a plus ribavirin 400 mg twice daily during 20 weeks after attaining undetectable viremia. The relationships between baseline patient-related variables, including IL28B genotype, plasma HCV-RNA, ribavirin dose/kg, peginterferon-α 2a and ribavirin levels with virological responses were analyzed. Only 4 patients showed lack of response and 5 patients dropped out due to adverse events related to the study medication. Overall, sustained virologic response (SVR) rates were 58.3% by intention-to-treat and 71.4% by per protocol analysis, respectively. Among patients with rapid virologic response (RVR), SVR and relapses rates were 92.6% and 7.4%, respectively. No relationships were observed between viral responses and ribavirin dose/kg, peginterferon-α 2a concentrations, ribavirin levels or rs129679860 genotype. Conclusions: Weekly 135 μg pegIFN-α 2a could be as effective as the standard 180 μg dose, with a very low incidence of severe adverse events. A 24-week treatment duration appears to be appropriate in patients achieving RVR, but extending treatment up to just 20 weeks beyond negativization of viremia is associated with a high relapse rate in those patients not achieving RVR. There was no influence of IL28B genotype on the virological responses. © 2012 López-Cortés et al.Funding provided by Fundación Pública Andaluza para la gestión de la Investigación en Salud de Sevilla. Hospitales Universitarios Virgen del Rocío. Seville, Spain. The enzyme-linked immunosorbent assay Hu-INF-α kits for determination of pegIFN-α-2a were financed by Roche Pharma, S.A. (Spain).Peer Reviewe
Life beyond 30: Probing the-20 < M (UV) <-17 Luminosity Function at 8 < z < 13 with the NIRCam Parallel Field of the MIRI Deep Survey
We present the ultraviolet luminosity function and an estimate of the cosmic star formation rate density at 8 8 galaxy candidates based on their dropout nature in the F115W and/or F150W filters, a high probability for their photometric redshifts, estimated with three different codes, being at z > 8, good fits based on χ 2 calculations, and predominant solutions compared to z < 8 alternatives. We find mild evolution in the luminosity function from z ∼ 13 to z ∼ 8, i.e., only a small increase in the average number density of ∼0.2 dex, while the faint-end slope and absolute magnitude of the knee remain approximately constant, with values α = − 2.2 ± 0.1, and M * = − 20.8 ± 0.2 mag. Comparing our results with the predictions of state-of-the-art galaxy evolution models, we find two main results: (1) a slower increase with time in the cosmic star formation rate density compared to a steeper rise predicted by models; (2) nearly a factor of 10 higher star formation activity concentrated in scales around 2 kpc in galaxies with stellar masses ∼108 M ⊙ during the first 350 Myr of the universe, z ∼ 12, with models matching better the luminosity density observational estimations ∼150 Myr later, by z ∼ 9
Tele-entomology and tele-parasitology: A citizen science-based approach for surveillance and control of Chagas disease in Venezuela.
Chagas Disease (CD), a chronic infection caused by the Trypanosoma cruzi parasite, is a Neglected Tropical Disease endemic to Latin America. With a re-emergence in Venezuela during the past two decades, the spread of CD has proved susceptible to, and inhibitable by a digital, real-time surveillance system effectuated by Citizen Scientists in communities throughout the country. The #TraeTuChipo (#BringYourKissingBug) campaign implemented in January 2020, has served as such a strategy counting on community engagement to define the current ecological distribution of CD vectors despite the absence of a functional national surveillance program. This pilot campaign collected data through online surveys, social media platforms, and/or telephone text messages. A total of 79 triatomine bugs were reported from eighteen Venezuelan states; 67 bugs were identified as Panstrongylus geniculatus, 1 as Rhodnius pictipes, 1 as Triatoma dimidiata, and 10 as Triatoma maculata. We analyzed 8 triatomine feces samples spotted from 4 Panstrongylus geniculatus which were confirmed positive by qPCR for T. cruzi. Further molecular characterization of discrete typing units (DTUs), revealed that all samples contained TcI, the most highly diverse and broadly distributed strain of T. cruzi. Moreover, analysis of the mitochondrial 12S gene revealed Myotis keaysi, Homo sapiens, and Gallus gallus as the main triatomine feeding sources. This study highlights a novel Citizen Science approach which may help improve the surveillance systems for CD in endemic countries
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.
INTRODUCTION: We have hypothesized that incompatibility between the G1m genotype of the patient and the G1m1 and G1m17 allotypes carried by infliximab (INX) and adalimumab (ADM) could decrease the efficacy of these anti-tumor necrosis factor (anti-TNF) antibodies in the treatment of rheumatoid arthritis (RA).
METHODS: The G1m genotypes were analyzed in three collections of patients with RA totaling 1037 subjects. The first, used for discovery, comprised 215 Spanish patients. The second and third were successively used for replication. They included 429 British and Greek patients and 393 Spanish and British patients, respectively. Two outcomes were considered: change in the Disease Activity Score in 28 joint (ΔDAS28) and the European League Against Rheumatism (EULAR) response criteria.
RESULTS: An association between less response to INX and incompatibility of the G1m1,17 allotype was found in the discovery collection at 6 months of treatment (P = 0.03). This association was confirmed in the replications (P = 0.02 and 0.08, respectively) leading to a global association (P = 0.001) that involved a mean difference in ΔDAS28 of 0.4 units between compatible and incompatible patients (2.3 ± 1.5 in compatible patients vs. 1.9 ± 1.5 in incompatible patients) and an increase in responders and decrease in non-responders according to the EULAR criteria (P = 0.03). A similar association was suggested for patients treated with ADM in the discovery collection, but it was not supported by replication.
CONCLUSIONS: Our results suggest that G1m1,17 allotypes are associated with response to INX and could aid improved therapeutic targeting in RA
- …